Recovery plan amendment expands scope of support for strategic health research
France plans to increase support for health research and innovation, following an amendment to the country’s Strategic Contract for the health industries and technologies sector.
First signed in 2019, the Strategic Contract is undergoing a three-part amendment aimed at responding to lessons learned during the coronavirus pandemic. This will include increasing pharmaceutical production in France, and broadening the use of information technology in healthcare and medicine.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.